Navigation Links
FDA approves Watson Pharmaceuticals' Oxytrol patch

The Food and Drug Administration has approved a new patch developed by Watson Pharmaceuticals Inc., for the treatment of an overactive bladder. The patch called Oxytrol (generic: oxybutynin transdermal system) reduces urinary urge incontinence, urinary urgency, and urinary frequency, according to the drug's maker. Oral forms of oxybutynin has been around for around 25 years but it has not been popular with patients due to side effects like// dry mouth and constipation. The patch delivers about 3.9mg of oxybutynin per day through a transdermal delivery system i.e., through the skin. The patch which needs to be applied to the abdomen, hip or buttocks twice a week helps better management of the side effects. The only side effect that the patch produced was itching in 14% to 16.8% of patients during the clinical trials. However, oxytrol is not recommended for patients who are at a risk of urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. The drug which will be available in the market by the end of May 2003 was approved after clinical trials involving more than 1000 people.


'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves surgical gel
3. FDA approves drug for rare liver disease
4. FDA approves first pocket-sized EKG machine
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. Pravastatin Launched by Watson Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... ... August 16, 2019 , ... The clinical trial supply chain landscape is constantly ... , Join Just In Time Manufacturing Solutions Manager at Almac Clinical Services , ... 11am EDT (4pm BST/UK) on a journey through time as it relates to clinical ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... market, has joined the esteemed Haute Beauty Network. , The Haute Beauty Network, ... to present Dr. Arnaoutakis as a hair restoration expert and our newest addition ...
(Date:8/15/2019)... ... 15, 2019 , ... With many students either starting college for the first time, and returning ... to the CDC , “there are about 20 million new cases of STDs each ... ages of 15 and 24. Young people are at greater risk of getting an STD.” ...
(Date:8/14/2019)... ... August 14, 2019 , ... Teguar Corporation has claimed the ... This list has long-been established as a mark of success for some of Americas ... Oracle. Teguar made the list in 2015, 2016 and 2017. This year, Teguar secured ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... ... August 21, 2019 , ... ... Healthcare’s Construction and Design Survey, has added Operational Readiness to its integrated ... overlay to clients’ capital projects, working with the clinical and operational leadership ...
(Date:8/21/2019)... ... August 21, 2019 , ... ... Module for its voice-activated notification and communication solution—with new features to help ... discharged patients. , Leveraging the innovative Amazon Alexa voice assistance technology, ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... hosting their 2nd Annual National Sports Summit, August 25-26 at the Hyatt Place ... clinical leaders from all major professional sports programs to discuss progress made over ...
Breaking Medicine Technology: